Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The complement system plays a paradoxical role in the development and expression of autoimmunity in humans. The activation of complement in systemic lupus erythematosus (SLE) contributes to tissue injury. In contrast, inherited deficiency of classical pathway components, particularly C1q (ref. 1), is powerfully associated with the development of SLE. This leads to the hypothesis that a physiological action of the early part of the classical pathway protects against the development of SLE (ref. 2) and implies that C1q may play a key role in this respect. C1q-deficient (C1qa-/-) mice were generated by gene targeting and monitored for eight months. C1qa-/- mice had increased mortality and higher titres of autoantibodies, compared with strain-matched controls. Of the C1qa-/- mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls. The phenotype associated with C1q deficiency was modified by background genes. These findings are compatible with the hypothesis that C1q deficiency causes autoimmunity by impairment of the clearance of apoptotic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Casciola-Rosen, L. A., Anhalt, G., & Rosen, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,717
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Casciola-Rosen, L., Rosen, A., Petri, M., & Schlissel, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1624 · Cited by 482
Baker, A. J., Mooney, A., Hughes, J., Lombardi, D., Johnson, R. J., & Savill, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117565 · Cited by 404
LeFeber, W. P., Norris, D. A., Ryan, S. R., Huff, J. C., Lee, L. A., Kubo, M., Boyce, S. T., Kotzin, B. L., & Weston, W. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111569 · Cited by 335
Complement deficiency and disease
Morgan, B. P., & Walport, M. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90003-c · Cited by 302
Self-citationNovel packages of viral and self-antigens are generated during apoptosis.
Rosen, A., Casciola-Rosen, L., & Ahearn, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1557 · Cited by 246
Hereditary C1q deficiency and systemic lupus erythematosus
(1994) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068955 · Cited by 207
Self-citationGolan, T. D., Elkon, K. B., Gharavi, A. E., & Krueger, J. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115922 · Cited by 165
Subnucleosome structures as substrates in enzyme-linked immunosorbent assays
Burlingame, R. W., & Rubin, R. L. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90380-e · Cited by 124
Cited by
Items 901–1,000 of 1,000
Rajasinghe, L. D., Chauhan, P., Wierenga, K. A., Evered, A. O., Harris, S. N., Bates, M. A., Gavrilin, M. A., & Pestka, J. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02179 · Cited by 25
Ex Vivo Test for Measuring Complement Attack on Endothelial Cells: From Research to Bedside
Meuleman, M.-S., Duval, A., Frémeaux‐Bacchi, V., Roumenina, L. T., & Chauvet, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.860689 · Cited by 24
“The assay was then used to demonstrate and explore complement activation and participation in the pathophysiology of several diseases, including C3G (14, 92), HELLP syndrome and pre-eclampsia (91, 105), TMA associated with severe hypertension (89, 106), drug-induced TMA (90), SCD (29), hemolytic anemia (97, 98), SLE (…”
BackgroundInfluentialNew C1q mutation in a Tunisian family
Jlajla, H., Sellami, M. K., Sfar, I., LAADHAR, L., ZERZERI, Y., Abdelmoula, M. S., Gorgi, Y. L., Dridi, M. F. B., & Makni, S. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.10.010 · Cited by 24
Apoptosis in glomerulonephritis
Hughes, J., & Savill, J. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000172728.82993.4e · Cited by 24
Miller, C. W. T., Wilgenbusch, S., Michael, M., Chi, D. S., Youngberg, G. A., & Krishnaswamy, G. A. (2010) · Clinical and Molecular Allergy · doi:10.1186/1476-7961-8-6 · Cited by 25
“In addition, MBL has an important role in clearance of apoptotic cells (MBL is recruited from noncutaneous sources to bind apoptotic keratinocytes and induce their uptake by dendritic cells) [38], the accumulation of which can favor autoimmunity, as the release of intracellular components triggers inflammatory cytokin…”
BackgroundSystemic lupus erythematosus and dysregulated apoptosis--what is the evidence?
McHugh, N. J. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.3.242 · Cited by 24
Marshak‐Rothstein, A., Busconi, L., Rifkin, I. R., & Viglianti, G. A. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.04.005 · Cited by 24
“Experimental models include C1q deficiency [85] and deficient expression of”
BackgroundApoptosis and immune responses to self
Navratil, J. S., Sabatine, J. M., & Ahearn, J. M. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00110-8 · Cited by 26
“The hypothesis that C1q participates in the clearance of apoptotic cells also is supported by studies of C1q-deficient mice [79,80].”
BackgroundResultLicht, R., Jacobs, C. W. M., Tax, W. J. M., & Berden, J. H. M. (2001) · Lupus · doi:10.1191/096120301672276558 · Cited by 24
Al‐Ejeh, F., Staudacher, A. H., Smyth, D. R., Darby, J. M., Denoyer, D., Tsopelas, C., Hicks, R. J., & Brown, M. P. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.130559 · Cited by 23
“To examine this, we used C1q knock-out (C1qa2/2) mice, which lack the first component of the complement pathway (C1q) and manifest an accumulation of apoptotic cells in the glomeruli (23).”
MethodPetrisko, T. J., Gómez-Arboledas, Á., & Tenner, A. J. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.09.003 · Cited by 23
Chapter 1 Immune Regulation by B Cells and Antibodies
Hoehlig, K., Lampropoulou, V., Roch, T., Neves, P., Calderón‐Gómez, E., Anderton, S. M., Steinhoff, U., & Fillatreau, S. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00401-x · Cited by 34
SLE ‐associated risk factors affect DC function
Son, M., Kim, S. J., & Diamond, B. (2015) · Immunological Reviews · doi:10.1111/imr.12348 · Cited by 23
“Studies in mice suggest that C1q deficiency acts as a diseaseaccelerating factor on genetic backgrounds that predispose to the development of SLE (194).”
BackgroundCorpse disposal after apoptosis
Rovere, P. Q., & Dumitriu, I. E. (2003) · APOPTOSIS · doi:10.1023/a:1025538324077 · Cited by 24
Jordö, E. D., Wermeling, F., Chen, Y., & Karlsson, M. C. I. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.01.010 · Cited by 25
Pan, Z.-J., Davis, K., Maier, S. M., Bachmann, M. P., Kim-Howard, X., Keech, C. L., Gordon, T. P., McCluskey, J., & Farris, A. D. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.03001.x · Cited by 23
B cells in glomerulonephritis: focus on lupus nephritis
Clatworthy, M. R., & Smith, K. G. C. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0092-1 · Cited by 23
“C1q-deficient mice show high levels of ANAs and increased numbers of apoptotic bodies within glomeruli, suggesting a defect in clearance of apoptotic debris [51].”
BackgroundKim, T., Park, M., Nepomuceno, R. R., Palmarini, G., Winokur, S. T., Cotman, C. A., Bengtsson, U., & Tenner, A. J. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00057-2 · Cited by 23
“…documenting the induction of C1q expression in a variety of cell types upon injury (Goldsmith et al., 1997), infection (Dietzschold et al., 1995; Dandoy-Dron et al., 1998), or other trauma (Johnson et al., 1992; Shen et al., 1997; Huang et al., 1999) is consistent with a cellular response that…”
BackgroundA Critical Role for FcγRIIB in the Induction of Rheumatoid Factors
Moll, T., Nitschke, L., Carroll, M. C., Ravetch, J. V., & Izui, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4724 · Cited by 23
“In contrast, C1q, C2, and C4 are protective against the development of anti-DNA autoantibody responses; this is consistent with the findings that C1q- or C4-deficiency promotes the spontaneous production of anti-DNA autoantibodies in mice (27, 29, 30).”
BackgroundGenetics and systemic lupus erythematosus
Tsao, B. P., & Grossman, J. M. (2001) · Current Rheumatology Reports · doi:10.1007/s11926-001-0017-2 · Cited by 23
“Furthermore, 50% of the homozygous C1q-deficient mice develop high titer anti-nuclear antibodies, and 25% develop glomerulonephritis with immune deposits [ 16 ].”
BackgroundHolers, V. M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199910)42:10<2023::aid-anr1>3.0.co;2-v · Cited by 23
Accumulation of immune complexes in glomerular disease is independent of locally synthesized c3
Sheerin, N. S., Abe, K., Risley, P., & Sacks, S. H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070515 · Cited by 22
“In particular, C1q deficiency has been associated with reduced clearance of apoptotic cells (4) and the development of antibody-mediated glomerulonephritis (5).”
BackgroundCheng, T.-W., Liu, X.-B., Faulkner, R. L., Stephan, A. H., Barres, B. A., Huberman, A. D., & Cheng, H.-J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3455-10.2010 · Cited by 22
“html) and in some cases mated with complement-deficient (C1q knock-out) mice (Botto et al., 1998) to generate CB2-GFP::C1q / mice.”
BackgroundFathi, F., Atapour, A., Eskandari, N., Keyhanmehr, N., Hafezi, H., Mohammadi, S., & Motedayyen, H. (2019) · International Journal of Immunopathology and Pharmacology · doi:10.1177/2058738419863238 · Cited by 22
Host–Pathogen Interactions in Streptococcal Immune Sequelae
Nitsche-Schmitz, D. P., & Chhatwal, G. S. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_296 · Cited by 22
“Similar to subepithelial humps in PSGN, glomerular depositions in the C1q deficient mice contained complement factor 3 (Botto et al., 1998), indicating activity of the lectin or alternative pathway of complement.”
BackgroundInfluentialMechanisms and markers of vascular damage in ANCA-associated vasculitis
Haubitz, M., Dhaygude, A. P., & Woywodt, A. (2009) · Autoimmunity · doi:10.1080/08916930903002503 · Cited by 24
“[92] Botto M, Dell’Agnola C, Bygrave AE, et al.”
BackgroundMolecular Basis of Human Complement C1s Deficiency
Endo, Y., Kanno, K., Takahashi, M., Yamaguchi, K., Kohno, Y., & Fujita, T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2180 · Cited by 22
Macrophage-mediated clearance of cells undergoing caspase-3-independent death
Turner, C., Devitt, A., Parker, K. M. A., MacFarlane, M., Giuliano, M., Cohen, G. M., & Gregory, C. D. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401170 · Cited by 22
The role of complement in autoimmune renal disease
Seelen, M. A., & Daha, M. R. (2006) · Autoimmunity · doi:10.1080/08916930600739688 · Cited by 23
“The important role of C1q has been most clearly shown in studies with C1q-deficient mice [25].”
BackgroundThe role of dendritic cells in neurodegenerative diseases.
Iribarren, P., Cui, Y., Le, Y., & Wang, J. M. (2002) · PubMed · Cited by 22
Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases
Ramaswamy, M., Deng, M., & Siegel, R. M. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.225 · Cited by 24
“C1q-knockout mice develop glomerulonephritis, accumulate apoptotic bodies and exhibit increased mortality”
Genetic models for the clearance of apoptotic cells
Cohen, P. L., & Caricchio, R. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.04.003 · Cited by 23
“C1q Peritoneum, kidney SLE [11] CR2 ND SLE [13] SAP/CRP Circulating debris SLE [16] DNase I Circulating debris SLE [42] Mer Lymphoid tissue SLE [29] TGase2 Lymphoid tissue (after induction of in situ apoptosis) SLE [31]”
BackgroundKolowos, W., Gaipl, U. S., Voll, R. E., Frank, C. H. N., Haas, J., Beyer, T. D., Kalden, J. R., & i, M. H. (2001) · Lupus · doi:10.1191/096120301671176280 · Cited by 22
Cortés-Hernández, J., Fossati‐Jimack, L., Carugati, A., Potter, P. K., Walport, M. J., Cook, H. T., & Botto, M. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01998.x · Cited by 26
Self-citationFan, H., Patel, V. A., Longacre, A., & Levine, J. S. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705408 · Cited by 23
Update on systemic lupus erythematosus: autoantibodies and apoptosis
Gordon, C., & Salmon, M. (2001) · Clinical Medicine · doi:10.7861/clinmedicine.1-1-10 · Cited by 23
Apoptosis in lupus pathogenesis
Greidinger, E. L. (2001) · Frontiers in bioscience · doi:10.2741/a688 · Cited by 26
Fat(al) attraction: Oxidized lipids act as “eat‐me” signals
Fadeel, B., Quinn, P. J., Xue, D., & Kagan, V. E. (2007) · HFSP journal · doi:10.2976/1.2800110 · Cited by 23
“Moreover, when certain engulfment genes are deleted in mice, these animals develop profound autoimmune disease (Botto et al., 1998; Hanayama et al., 2004), indicating that faithful execution of apoptosis without subsequent clearance of apoptotic cells may have deleterious consequences.”
BackgroundEfferocytosis and Its Role in Rheumatic Diseases
Tang, X., Peng, Y., Jiang, Z., Yu, B., Peng, D., Xie, X., Li, F., & Ge, Y. L. (2025) · Arthritis & Rheumatology · doi:10.1002/art.43268 · Cited by 21
“59 In fact, apart from the NR1H3 (which encodes LXR) being linked to multiple sclerosis, 60 no associations have been reported between genes encoding G2A or Xkr8 and human autoimmune diseases.”
Hammond, J. W., Qiu, W. Q., Marker, D. F., Chamberlain, J. M., Greaves‐Tunnell, W., Bellizzi, M. J., Lu, S., & Gelbard, H. A. (2018) · Glia · doi:10.1002/glia.23511 · Cited by 21
Autoimmunity: Basic Mechanisms and Implications in Endocrine Diseases
Ballotti, S., Chiarelli, F., & de Martino, M. (2006) · Hormone Research in Paediatrics · doi:10.1159/000094251 · Cited by 23
Petry, F., Jakobi, V., Wagner, S., Tessema, T. S., Thiel, S., & Loos, M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.04.010 · Cited by 21
Self-citationMonocytosis and accelerated activation of lymphocytes in C1q‐deficient autoimmune‐prone mice
Trendelenburg, M., Manderson, A. P., Fossati‐Jimack, L., Walport, M. J., & Botto, M. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01940.x · Cited by 21
Self-citationRobson, M. G., Cook, H. T., Pusey, C. D., Walport, M. J., & Davies, K. A. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02233.x · Cited by 21
Self-citationRohrer, B., Demos, C., Frigg, R., & Grimm, C. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.08.017 · Cited by 22
“C1qα −/ − mice on a pure C57BL/6 background were generated by Botto and colleagues (Botto et al. 1998).”
MethodUpdate on complement in the pathogenesis of systemic lupus erythematosus
Molina, H. D. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200209000-00002 · Cited by 21
Poppelaars, F., Holers, V. M., & Thurman, J. M. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188347 · Cited by 20
Renaudineau, Y., Chauveau, D., Faguer, S., Huart, A., Ribes, D., Pugnet, G., Sailler, L., Jamme, T., Treiner, E., Fortenfant, F., et al. (2024) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2024.100244 · Cited by 20
“A defect in the classical complement pathway is associated with SLE development and flares by impairment of the immune complex ’ s clearance [36].”
BackgroundTong, H. H., Lambert, G. M., Li, Y. X., Thurman, J. M., Stahl, G. L., Douthitt, K., Clancy, C. R., He, Y., & Bowman, A. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095160 · Cited by 20
“C57BL/6 mice homozygous for gene deficiencies of C1qa (C1qa) and factor B (Bf ) were generated as previously described [24], [25].”
MethodMacrophages and Recently Identified Forms of Cell Death
Sanz, A. B., Sánchez-Niño, M. D., Izquierdo, M. C., González–Espinoza, L., Ucero, A. C., Poveda, J., Ruiz‐Andrés, O., Ruiz‐Ortega, M., Selgas, R., Egido, J., et al. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.771183 · Cited by 24
“This is the case of lupus nephritis, characterized by the presence of antibodies against apoptosis-generated autoantigens, immune deposits and multiple apoptotic cell bodies in the kidney [50].”
BackgroundComplement Factor H Modulates Splenic B Cell Development and Limits Autoantibody Production
Kiss, M. G., Ozsvár-Kozma, M., Porsch, F., Göderle, L., Papac-Miličević, N., Gritti, B. B., Tsiantoulas, D., Pickering, M. C., & Binder, C. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01607 · Cited by 20
“Uncontrolled complement activation resulting from defective regulation leads to the accumulation of cellular waste which does not only promote proinflammatory and cytolytic effects inducing host tissue damage but also contributes to the rise of autoimmune conditions as it is seen upon either C1q (7), C4 (8, 9), or CR2…”
BackgroundC1q Regulates Horizontal Cell Neurite Confinement in the Outer Retina
Burger, C. A., Jiang, D., Li, F., & Samuel, M. A. (2020) · Frontiers in Neural Circuits · doi:10.3389/fncir.2020.583391 · Cited by 20
“To examine the role of C1q in retina development, we obtained C1qa null mice in which the A chain of C1q is deleted, resulting in C1q loss-of-function (Botto et al., 1998).”
BackgroundMethodFelux, J., Erbacher, A., Breckler, M., Hervé, R., Lemeiter, D., Mannherz, H. G., Napirei, M., Rammensee, H., & Decker, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613597 · Cited by 20
“Mice carrying the C1qa-KO were generated by Marina Botto (31).”
BackgroundMethodAlvarez-Domínguez, C., Carrasco-Marín, E., López-Mato, P., & Leyva‐Cobián, F. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00083.x · Cited by 24
Activation of the lectin pathway in murine lupus nephritis
Trouw, L. A., Seelen, M. A., Duijs, J. M. G. J., WAGNER, S., Loos, M., Bajema, I. M., van Kooten, C., ROOS, A., & Daha, M. R. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.09.024 · Cited by 20
Self-citationA Two-step Hypothesis for the Appearance of Autoimmune Disease
Salaman, M. R. (2003) · Autoimmunity · doi:10.1080/0891693031000068637 · Cited by 20
Studies of the humoral immune response
Kelsoe, G. H. (2000) · Immunologic Research · doi:10.1385/ir:22:2-3:199 · Cited by 20
Genetic epidemiology: systemic lupus erythematosus.
Ahmad, Y. A., & Bruce, I. N. (2001) · Arthritis Research · doi:10.1186/ar324 · Cited by 20
“These models have shown several important pathogenic abnormalities, including reduced macrophage clearance of apoptotic cells and increased concentrations of apoptotic bodies, in tissue samples associated with development of glomerulonephritis [10–13].”
Genetic Susceptibility and Class III Complement Genes
Atkinson, J. P., & Yu, C. Y. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10002-6 · Cited by 20
Chen, X., Gula, H., Pius, T., Ou, C., Gomozkova, M., Wang, L., Schneewind, O., & Missiakas, D. M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220765120 · Cited by 19
“In C1q-deficient animals (C1qa −/− ), the A-chain of C1q has been deleted resulting in loss of C1q expression (46).”
Case, J. B., Sanapala, S., Dillen, C. A., Rhodes, V., Zmasek, C. M., Chicz, T. M., Switzer, C., Scheaffer, S. M., Georgiev, G. P., Jacob-Dolan, C., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.10.016 · Cited by 20
Namjou, B., Keddache, M. A., Fletcher, D., Dillon, S., Kottyan, L. C., Wiley, G. B., Gaffney, P. M., Wakeland, B., Liang, C., Wakeland, E., et al. (2012) · Lupus · doi:10.1177/0961203312443993 · Cited by 21
Bergström, J. J. E., & Heyman, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143841 · Cited by 19
Complement components as promoters of immunological tolerance in dendritic cells
Luque, A., Serrano, I., & Aran, J. M. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.11.022 · Cited by 19
Cell death recognition model for the immune system
Sun, E. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.05.049 · Cited by 21
Manderson, A. P., Carlucci, F., Lachmann, P. J., Lazarus, R. A., Festenstein, R., Cook, H. T., Walport, M. J., & Botto, M. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1936 · Cited by 19
“Robson MG, Cook HT, Botto M, Taylor PR, Busso N, Salvi R, Pusey CD, Walport MJ, Davies KA: Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice.”
BackgroundSelf-citationAgrawal, N., Chiang, L.-K., & Rifkin, I. R. (2006) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2005.09.002 · Cited by 22
Environmental adjuvants, apoptosis and the censorship over autoimmunity
Rovere, P. Q., Manfredi, A. A., & Sabbadini, M. G. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.04.013 · Cited by 19
Deletion of p21 (WAF-1/Cip1) Does Not Induce Systemic Autoimmunity in Female BXSB Mice
Lawson, B. R., Kono, D. H., & Theofilopoulos, A. N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5928 · Cited by 22
“For example, 55% of C57BL/6 129/Ola mice deleted of the C1q gene developed signs of systemic autoimmunity, whereas 33% of the nondeleted mice also displayed some of these characteristics (27).”
BackgroundCirculating endothelial cells in renal disease: markers and mediators of vascular damage
Woywodt, A., Kirsch, T., & Haubitz, M. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm680 · Cited by 19
“Interestingly, disturbed clearance of apoptotic cells has also been implicated in systemic lupus erythematosus [37].”
BackgroundMikolajczyk, T. P., Skiba, D. S., Batko, B. P., Krezelok, M., Wilk, G., Osmenda, G., Pryjma, J. R., & Guzik, T. J. (2014) · Lupus · doi:10.1177/0961203314541316 · Cited by 18
Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus
Radic, M. Z., Neeli, I., & Marion, T. N. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2026921 · Cited by 19
Distinct Roles of Classical and Lectin Pathways of Complement in Preeclamptic Placentae
Belmonte, B., Mangogna, A., Gulino, A., Cancila, V., Morello, G., Agostinis, C., Bulla, R., Ricci, G., Fraggetta, F., Botto, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.882298 · Cited by 18
“C1q deficient mice (C1qa) backcrossed on the C57BL/6 background were generated as previously described (34).”
MethodSelf-citationEfferocytosis: Current status and future prospects in the treatment of autoimmune diseases
Li, Q., Liu, H., Yin, G., & Xie, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28399 · Cited by 19
The genetic basis for systemic lupus erythematosus
Perdriger, A., Werner-Leyval, S., & Rollot, K. (2003) · Joint Bone Spine · doi:10.1016/s1297-319x(03)00007-1 · Cited by 22
Experimental Stroke Differentially Affects Discrete Subpopulations of Splenic Macrophages
McCulloch, L., Alfieri, A., & McColl, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01108 · Cited by 20
Morley, B. J., & Walport, M. J. (2000) · Elsevier eBooks · doi:10.1016/b978-012733360-1/50003-8 · Cited by 18
Self-citationBuyon, J. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-68566-3_15 · Cited by 29
Apoptosis in post-streptococcal glomerulonephritis
Savill, J., & Savill, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0600031203.x · Cited by 22
Of Mice and Men: The Relevance of the Mouse to the Study of Human SLE
Birmingham, D. J., Rovin, B. H., Yu, C. Y., & Hebert, L. A. (2001) · Immunologic Research · doi:10.1385/ir:24:2:211 · Cited by 22
Pathogenesis of Systemic Lupus Erythematosus
Hahn, B. H., & Tsao, B. P. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10074-9 · Cited by 19
Suen, J., Chuang, Y., & Chiang, B. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01438.x · Cited by 18
Difference in the way of macrophage recognition of target cells depending on their apoptotic states
Fujii, C., Shiratsuchi, A., Manaka, J., Yonehara, S., & Nakanishi, Y. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400920 · Cited by 21
Functional Roles of the Complement Immune System in Cardiac Inflammation and Hypertrophy
Hok, K. D., Rich, H. E., Shadid, A., Gunamalai, L., Mills, T., Thandavarayan, R. A., Banda, N. K., Doursout, M., Restrepo, M. I., & Shivshankar, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209931 · Cited by 18
“In an experimental study conducted in MRL/lpr mice (MRL/MpJ-Fas lpr/J) that develop SLE-like disease, Botto M et al. [85] demonstrated that deletion of C1q induced severe proliferative and crescentic glomerulonephritis, immune bodies, and high titers of autoantibodies.”
C1q as a target molecule to treat human disease: What do mouse studies teach us?
Schulz, K., & Trendelenburg, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958273 · Cited by 17
“In the setting of C1q deficiency the striking amount of apoptotic cells (9), the fact that autoantibodies directed against proteins contained in apoptotic blebs as well as the well accepted role of C1q in the removal of cell debris has led to the waste disposal hypothesis: a prolonged exposure of the body to cell debr…”
BackgroundInfluentialLi, Q., Li, Y. X., Douthitt, K., Stahl, G. L., Thurman, J. M., & Tong, H. H. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.08.002 · Cited by 17
Negative regulation of human mononuclear phagocyte function
Hedl, M., & Abraham, C. (2013) · Mucosal Immunology · doi:10.1038/mi.2012.139 · Cited by 19
O death where is thy sting? Immunologic tolerance to apoptotic self
Ravishankar, B., & McGaha, T. L. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1261-0 · Cited by 17
“C1q SLe [186]”
Divergent members of a single autoreactive B cell clone retain specificity for apoptotic blebs
Neeli, I., Richardson, M. M., Khan, S. N., Nicolo, D., Monestier, M., & Radic, M. Z. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.027 · Cited by 17
“Consistent with this view, genetic defects leading to increased abundance of apoptotic cells are among the most potent risk factors for the development of systemic autoimmunity (Botto et al., 1998; Bickerstaff et al., 1999; Lu and Lemke, 2001; Scott et al., 2001; Cohen et al., 2002).”
BackgroundCresci, G., Allende, D. S., McMullen, M. R., & Nagy, L. E. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.10.017 · Cited by 19
Using animal models to determine the significance of complement activation in Alzheimer's disease.
Loeffler, D. A. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-18 · Cited by 21
The contribution of the programmed cell death machinery in innate immune cells to lupus nephritis
Tsai, F., Perlman, H., & Cuda, C. M. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.10.007 · Cited by 17
“C1q-deficient mice also develop SLE-like disease, including glomerulonephritis [84, 86].”
BackgroundKlint, C., Truedsson, L., Andreasson, A., Johansson, I., & Sturfelt, G. K. (2000) · Lupus · doi:10.1191/096120300680198999 · Cited by 17
Bessler, M., Rosti, V., Peng, Y., Cattoretti, G., Notaro, R., Ohsako, S., Elkon, K. B., & Luzzatto, L. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200209)32:9<2607::aid-immu2607>3.0.co;2-h · Cited by 17
The complement system in systemic lupus erythematosus
Sturfelt, G. K. (2002) · Scandinavian Journal of Rheumatology · doi:10.1080/rhe.31.3.129.132 · Cited by 17
Apoptosis in glomerulonephritis
Hughes, J., Cailhier, J., Watson, S., & Savill, J. (2004) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2004.04.004 · Cited by 19
The danger model in deciphering autoimmunity
Tveita, A. A. (2010) · Rheumatology · doi:10.1093/rheumatology/keq004 · Cited by 21
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5
Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6
(2000) · Pure Amsterdam UMC · doi:10.1002/1521-4141(200007)30:7 · Cited by 1
(2002) · doi:10.1002/1521-4141(200206)32:6<1726::aid-immu1726>3.0.co;2-r
Metadata
- Authors
- Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J.
- Affiliations
- Imperial College London (GB)
- Institute of Medical Microbiology and Hygiene (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Walport, Mark J.
- Venue
- Nature Genetics
- Published
- 1998-05
- Volume
- 19
- Issue
- 1
- Pages
- 56-59
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2067217824
- Cited by
- 1,434
- References
- 21
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 22 · 2023: 18 · 2022: 27 · 2021: 29 · 2020: 20 · 2019: 39 · 2018: 29 · 2017: 37 · 2016: 27 · 2015: 36 · 2014: 47 · 2013: 39 · 2012: 62
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- C1q deficiency, glomerulonephritis, apoptotic bodies, systemic lupus erythematosus, classical complement pathway, autoimmunity, autoantibodies, efferocytosis, genetic background effects, immune deposits
- MeSH terms
- Animals, Antibodies, Antinuclear, Autoantigens, Crosses, Genetic, Glomerulonephritis, Homozygote, Kidney Glomerulus, Microscopy, Electron, Complement C1q, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.